High-Altitude Pulmonary Edema Clinical Presentation
- Author: Rohit Goyal, MD; Chief Editor: Zab Mosenifar, MD more...
History
- High-altitude pulmonary edema (HAPE) generally occurs 1-4 days after rapid ascent to altitudes in excess of 2500 m (8000 ft). Young people and previously acclimatized people reascending to a high altitude following a short stay at low altitude seem more predisposed to HAPE. Cold weather and physical exertion at high altitude are other predisposing factors.
- The earliest indications are decreased exercise tolerance and slow recovery from exercise.
- The person usually notices fatigue, weakness, and dyspnea on exertion.
- The condition typically worsens at night, and tachycardia and tachypnea occur at rest. Periodic breathing during sleep is almost universal in sojourners at high altitude.
- Cough, frothy sputum, cyanosis, rales, and dyspnea progressing to severe respiratory distress are symptoms of the disease.
- A low-grade fever, respiratory alkalosis, and leukocytosis are other common features.
- In severe cases, an altered mental status, hypotension, and death may result.
Physical
In addition to the symptoms discussed, high-altitude pulmonary edema (HAPE) is diagnosed by the presence of at least 2 of the following signs:
- Tachycardia
- Tachypnea
- Crackles on auscultation
- Central cyanosis
- Disproportionately low oxygen saturation relative to altitude
Causes
- Rapid ascent
- Physical exertion at high altitude
- Exposure to cold
Scherrer U, Rexhaj E, Jayet PY, Allemann Y, Sartori C. New insights in the pathogenesis of high-altitude pulmonary edema. Prog Cardiovasc Dis. May-Jun 2010;52(6):485-92. [Medline].
Fischer R, Lang SM, Bergner A, Huber RM. Monitoring of expiratory flow rates and lung volumes during a high altitude expedition. Eur J Med Res. Nov 16 2005;10(11):469-74. [Medline].
Eldridge MW, Braun RK, Yoneda KY, Walby WF. Effects of altitude and exercise on pulmonary capillary integrity: evidence for subclinical high-altitude pulmonary edema. J Appl Physiol. Mar 2006;100(3):972-80. [Medline].
Leshem E, Pandey P, Shlim DR, Hiramatsu K, Sidi Y, Schwartz E. Clinical features of patients with severe altitude illness in Nepal. J Travel Med. Sep-Oct 2008;15(5):315-22. [Medline].
Hartmann G, Tschop M, Fischer R, et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine. Mar 2000;12(3):246-52. [Medline].
Grunig E, Mereles D, Hildebrandt W, et al. Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. J Am Coll Cardiol. Mar 15 2000;35(4):980-7. [Medline].
Fagenholz PJ, Gutman JA, Murray AF, Noble VE, Thomas SH, Harris NS. Chest ultrasonography for the diagnosis and monitoring of high-altitude pulmonary edema. Chest. Apr 2007;131(4):1013-8. [Medline].
Maggiorini M. Prevention and treatment of high-altitude pulmonary edema. Prog Cardiovasc Dis. May-Jun 2010;52(6):500-6. [Medline].
Zhou Q. Standardization of methods for early diagnosis and on-site treatment of high-altitude pulmonary edema. Pulm Med. 2011;2011:190648. [Medline]. [Full Text].
Fagenholz PJ, Gutman JA, Murray AF, Harris NS. Treatment of high altitude pulmonary edema at 4240 m in Nepal. High Alt Med Biol. Summer 2007;8(2):139-46. [Medline].
[Best Evidence] Maggiorini M, Brunner-La Rocca HP, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med. Oct 3 2006;145(7):497-506. [Medline].
Mounier R, Amonchot A, Caillot N, Gladine C, Citron B, Bedu M, et al. Pulmonary arterial systolic pressure and susceptibility to high altitude pulmonary edema. Respir Physiol Neurobiol. Dec 15 2011;179(2-3):294-9. [Medline].
[Guideline] Hill DR, Ericsson CD, Pearson RD, et al. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis. Dec 15 2006;43(12):1499-539. [Medline].
[Guideline] Rice SG. Medical conditions affecting sports participation. Pediatrics. Apr 2008;121(4):841-8. [Medline].
Bärtsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. Oct 31 1991;325(18):1284-9. [Medline].
van Patot MC, Leadbetter G 3rd, Keyes LE, Maakestad KM, Olson S, Hackett PH. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. High Alt Med Biol. Winter 2008;9(4):289-93. [Medline].
Bärtsch P. High altitude pulmonary edema. Med Sci Sports Exerc. Jan 1999;31(1 Suppl):S23-7. [Medline].
Bärtsch P. High altitude pulmonary edema. Respiration. 1997;64(6):435-43. [Medline].
Goetz AE, Kuebler WM, Peter K. High-altitude pulmonary edema. N Engl J Med. Jul 18 1996;335(3):206-7. [Medline].
Hackett PH, Rennie D, Levine HD. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet. Nov 27 1976;2(7996):1149-55. [Medline].
Klocke DL, Decker WW, Stepanek J. Altitude-related illnesses. Mayo Clin Proc. Oct 1998;73(10):988-92; quiz 992-3. [Medline].
Krieger BP, de la Hoz RE. Altitude-related pulmonary disorders. Crit Care Clin. Apr 1999;15(2):265-80, viii. [Medline].
Naeije R. Pulmonary circulation at high altitude. Respiration. 1997;64(6):429-34. [Medline].
Nayak NC, Roy S, Narayanan TK. Pathologic features of altitude sickness. Am J Pathol. Sep 1964;45:381-91. [Medline].
Schoene RB. Lung disease at high altitude. Adv Exp Med Biol. 1999;474:47-56. [Medline].
Schoene RB, Hackett PH, HornBein TF. High altitude. In: Murray JF, Nadel JA, eds. Textbook of Respiratory Medicine. Vol 2. Philadelphia, Pa: WB Saunders; 2000:2062-98.
Singh I, Khanna PK, Srivastava MC, Lal M, Roy SB, Subramanyam CS. Acute mountain sickness. N Engl J Med. Jan 23 1969;280(4):175-84. [Medline].

